Safety and Efficacy of High-Intensity Macrofocused Ultrasound for Solar Lentigo in Chinese Population

CompletedOBSERVATIONAL
Enrollment

21

Participants

Timeline

Start Date

November 16, 2023

Primary Completion Date

May 4, 2024

Study Completion Date

May 4, 2024

Conditions
Solar Lentigo
Interventions
DEVICE

High intensity focused ultrasound (MFUS One, Hunan Peninsula Medical Technology Co., Ltd., China)

Before treatment, a 2-3mm thick medical condensation gel is evenly applied on the face. Patients are to be treated with two macro-focused handpieces with focal depths at 3.0 mm (D3.0) and 4.5 mm (D4.5) on both side. Following the treatment, local cooling with an ice pack was performed for 10 min to reduce redness and swelling. Patients were followed up at 2, 4, 6, and 8 weeks. Clinical images and non-invasive skin assessments were collected at baseline and during each visit.

Trial Locations (1)

Unknown

Jiangsu Province Hospital, the First Affiliated Hospital of Nanjing Medical University, Nanjing

All Listed Sponsors
lead

The First Affiliated Hospital with Nanjing Medical University

OTHER

NCT06288607 - Safety and Efficacy of High-Intensity Macrofocused Ultrasound for Solar Lentigo in Chinese Population | Biotech Hunter | Biotech Hunter